Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE

This article was originally published in The Gray Sheet

Executive Summary

National Institute for Clinical Excellence (NICE) guidance to the UK's National Health Service focusing on the clinical and cost effectiveness of implantable cardioverter defibrillators (ICDs), released Sept. 29, recommends three-fold increase in utilization rate by Britons, from an estimated 17 per million in the population to 50 per million. The change could bring the usage rate in line with that of other European countries. The NICE guidance follows an extensive review of published clinical data and information submitted by ICD manufacturers (1"The Gray Sheet" Sept. 18, 2000, p. 15)....Separately, artificial hip joints become the first medical device category where performance data will be available to UK National Health Service trusts following the April release of a NICE guidance on hip prostheses. The central database will inform trusts of devices that best meet their requirements
Advertisement

Related Content

UK's NICE Could Issue ICD Guidance As Early As Sept. 25 - ABHI Officials
UK's NICE Could Issue ICD Guidance As Early As Sept. 25 - ABHI Officials
Advertisement
UsernamePublicRestriction

Register

MT013938

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel